whittenhalljr - Yes, my sentiments, exactly.
Also keep in mind that once the agreement with Denverson is 'realized', it will necessarily mean that SFIO then has cash in a bank account somewhere of about $110,000. Of course we all know that the $1M in Denverson IPO conv notes is sketchy at best (speculation), so I doubt any holder here is relying on that figure. But even if we assume that the IPO does not occur or it has poor performance, the main factor to think about is the little nugget of hope called, 'ONGOING ROYALTIES'.
SFIO has not 'claimed' to have a Euro patent for the device, it DOES have a patent in Europe for the device. The 'teaming' agreement with Denverson and their products outlines a sharing of the profits based on the sales Denverson makes abroad and so SFIO will receive royalties for as long as Denverson is turning a profit by selling ALL of the products (Denverson and SFIO) abroad.
Of course, if one has the opinion that Denverson will not be able to sell ANY products, whatsoever, then that is their right to that opinion, but remember, Denverson this time actually has financial backing of $3.5M; in the past the funding was toxic (Indenture), they are out of the picture now.
So if one wishes to assume that with a very small budget and low expenditures, Denverson, with their already rather large distribution network cannot land any agreements with other businesses to sell ALL of the products abroad (in any country), whilst having about $3.5 Million dollars backing up the success of their company then by all means, you are entitled to your opinion, though I do not share it. I think Denverson does have the potential to sell a decent supply of product and SFIO will gain quarterly revenues from these royalties with very little expense (will be profitable). JMHO ;)
GL
$SFIO!
News 
Market Data 
Discover 
